Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma
Journal of Clinical Oncology · 10.07.2024 · 42 (20) · 2415-2424
DOI: 10.1200/jco.23.02547 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.07.2024. Verfasst von Chengcheng Yan und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of Alabama at Birmingham, Birmingham, AL. Hauptthemen laut MEDLINE: Hodgkin Disease, Transplantation, Autologous, Clonal Hematopoiesis, Neoplasms, Second Primary. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Therapy-related myeloid neoplasm (t-MN) is a life-threatening complication of autologous peripheral blood stem cell transplantation (aPBSCT) for Hodgkin lymphoma (HL). Although previous studies have reported an association between clonal hematopoiesis (CH) in the infused PBSC product and subsequent post-aPBSCT risk of t-MN in patients with non-HL, information about patients with HL treated with aPBSCT is not available. METHODS We constructed a retrospective cohort of 321 patients with HL transplanted at a median age of 34 years (range, 18-71). Targeted DNA sequencing of PBSC products performed for CH-associated or myeloid malignancy-associated genes identified pathogenic mutations in these patients. RESULTS CH was identified in the PBSC product of 46 patients (14.3%) with most prominent representation of DNMT3A (n = 25), PPM1D (n = 7), TET2 (n = 7), and TP53 (n = 5) mutations. Presence of CH in the PBSC product was an independent predictor of t-MN (adjusted hazard ratio [aHR], 4.50 [95% CI, 1.54 to 13.19]). Notably all patients with TP53 mutations in the PBSC product developed t-MN, whereas none of the patients with DNMT3A mutations alone (without co-occurring TP53 or PPM1D mutations) did. Presence of TP53 and/or PPM1D mutations was associated with a 7.29-fold higher hazard of t-MN when compared with individuals carrying no CH mutations (95% CI, 1.72 to 30.94). The presence of TP53 and/or PPM1D mutations was also associated with a 4.17-fold higher hazard of nonrelapse mortality (95% CI, 1.25 to 13.87). There was no association between CH and relapse-related mortality. CONCLUSION The presence of TP53 and/or PPM1D mutations in the PBSC product increases the risk of post-aPBSCT t-MN and nonrelapse mortality among patients with HL and may support alternative therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Alabama at Birmingham, Birmingham, AL.
- Baylor College of Medicine, Houston, TX.
- Dana Farber Cancer Institute, Boston, MA.
- City of Hope, Duarte, CA.
- University of Nebraska, Omaha, NE.
- University of Minnesota, Minneapolis, MN.
ORCID-Profile: Chengcheng Yan, Melissa A Richard, Christopher J Gibson, Alysia Bosworth, David K Crossman, Purnima Singh, Saro H Armenian, Julie Vose, Daniel J Weisdorf, Benjamin L Ebert, Yutaka Yasui, Stephen J Forman, Smita Bhatia
Förderung
- NCI NIH HHS
Zitieren
APA
Yan, C., Richard, M. A., Gibson, C. J., He, J., Bosworth, A., Crossman, D. K., Singh, P., Hageman, L., Kalra, R., Armenian, S. H., Vose, J., Weisdorf, D. J., Ebert, B. L., Yasui, Y., Forman, S. J., Bhatia, R., & Bhatia, S. (2024). Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma. Journal of Clinical Oncology, 42(20), 2415-2424. https://doi.org/10.1200/jco.23.02547
Vancouver
Yan C, Richard MA, Gibson CJ, He J, Bosworth A, Crossman DK, et al. Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma. Journal of Clinical Oncology. 2024;42(20):2415-2424. doi:10.1200/jco.23.02547
BibTeX
@article{Yan2024,
author = {Yan, Chengcheng and Richard, Melissa A and Gibson, Christopher J and He, Jianbo and Bosworth, Alysia and Crossman, David K and Singh, Purnima and Hageman, Lindsey and Kalra, Rashi and Armenian, Saro H and Vose, Julie and Weisdorf, Daniel J and Ebert, Benjamin L and Yasui, Yutaka and Forman, Stephen J and Bhatia, Ravi and Bhatia, Smita},
title = {Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma},
journal = {Journal of Clinical Oncology},
year = {2024},
volume = {42},
number = {20},
pages = {2415--2424},
doi = {10.1200/jco.23.02547}
}
EUVIMED